These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3156197)

  • 1. Vasodilator properties of a family of bioactive atrial peptides in isolated perfused rat kidneys.
    Wakitani K; Currie MG; Geller DM; Needleman P
    J Lab Clin Med; 1985 Mar; 105(3):349-52. PubMed ID: 3156197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atriopeptins: bioactive peptides derived from mammalian cardiac atria.
    Currie MG; Geller DM; Cole BR; Siegel NR; Fok KK; Adams SP; Eubanks SR; Galluppi GR; Needleman P
    J Hypertens Suppl; 1984 Dec; 2(3):S309-12. PubMed ID: 6242557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atriopeptin biochemical pharmacology.
    Needleman P
    Fed Proc; 1986 Jun; 45(7):2096-100. PubMed ID: 3011519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An atrial peptide is a potent renal vasodilator substance.
    Oshima T; Currie MG; Geller DM; Needleman P
    Circ Res; 1984 May; 54(5):612-6. PubMed ID: 6233046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atriopeptins: a family of potent biologically active peptides derived from mammalian atria.
    Geller DM; Currie MG; Wakitani K; Cole BR; Adams SP; Fok KF; Siegel NR; Eubanks SR; Galluppi GR; Needleman P
    Biochem Biophys Res Commun; 1984 Apr; 120(2):333-8. PubMed ID: 6233969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative vascular pharmacology of the atriopeptins.
    Wakitani K; Oshima T; Loewy AD; Holmberg SW; Cole BR; Adams SP; Fok KF; Currie MG; Needleman P
    Circ Res; 1985 Apr; 56(4):621-7. PubMed ID: 3156691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and sequence analysis of bioactive atrial peptides (atriopeptins).
    Currie MG; Geller DM; Cole BR; Siegel NR; Fok KF; Adams SP; Eubanks SR; Galluppi GR; Needleman P
    Science; 1984 Jan; 223(4631):67-9. PubMed ID: 6419347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic processing of atriopeptin prohormone.
    Michener ML; Gierse JK; Seetharam R; Fok KF; Olins PO; Mai MS; Needleman P
    Mol Pharmacol; 1986 Dec; 30(6):552-7. PubMed ID: 2946928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide.
    Schwartz D; Geller DM; Manning PT; Siegel NR; Fok KF; Smith CE; Needleman P
    Science; 1985 Jul; 229(4711):397-400. PubMed ID: 3160114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion factors of high- to low-molecular-weight forms of atrial natriuretic factor.
    Trippodo NC; Januszewicz A; Cole FE; MacPhee AA; Pegram BL; Kardon MB
    Fed Proc; 1986 Jun; 45(7):2091-5. PubMed ID: 2940118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smooth muscle relaxing, acute and long-term blood pressure lowering effects of atriopeptins. Structure-activity relationship.
    De Mey JG; Cuthbert C; von Szendroi KG; van Malder G; Roba J
    J Pharmacol Exp Ther; 1987 Mar; 240(3):937-43. PubMed ID: 2951517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atriopeptin release from the isolated perfused rabbit heart.
    Currie MG; Sukin D; Geller DM; Cole BR; Needleman P
    Biochem Biophys Res Commun; 1984 Nov; 124(3):711-7. PubMed ID: 6508779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds.
    Garcia R; Thibault G; Cantin M; Genest J
    Am J Physiol; 1984 Jul; 247(1 Pt 2):R34-9. PubMed ID: 6540055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic activation of a bioactive cardiac peptide by in vitro trypsin cleavage.
    Currie MG; Geller DM; Cole BR; Needleman P
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1230-3. PubMed ID: 6230673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential structure-activity relationships of atrial peptides as natriuretics and renal vasodilators in the dog.
    Katsube N; Wakitani K; Fok KF; Tjoeng FS; Zupec ME; Eubanks SR; Adams SP; Needleman P
    Biochem Biophys Res Commun; 1985 Apr; 128(1):325-30. PubMed ID: 3157379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of aldosterone biosynthesis by atriopeptins in rat adrenal cells.
    Campbell WB; Currie MG; Needleman P
    Circ Res; 1985 Jul; 57(1):113-8. PubMed ID: 2988817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conversion of atrial natriuretic peptide (ANP)-(1-126) to ANP-(99-126) by rat serum: contribution to ANP cleavage in isolated perfused rat hearts.
    Gibson TR; Shields PP; Glembotski CC
    Endocrinology; 1987 Feb; 120(2):764-72. PubMed ID: 2948815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sequence of an atriopeptigen: a precursor of the bioactive atrial peptides.
    Geller DM; Currie MG; Siegel NR; Fok KF; Adams SP; Needleman P
    Biochem Biophys Res Commun; 1984 Jun; 121(3):802-7. PubMed ID: 6547606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of atriopeptin III on isolated perfused rat heart].
    Gao F; Niou GB; Zang YM; Shi PT; Shen TS; Yang JS
    Sheng Li Xue Bao; 1988 Dec; 40(6):597-602. PubMed ID: 2977860
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternative mechanisms for atriopeptin prohormone processing by isolated perfused rat hearts.
    Toki Y; Ito T; Shiono S; Siegel NR; Gierse JK; Wilkins MR; Needleman P
    J Pharmacol Exp Ther; 1990 Jul; 254(1):228-35. PubMed ID: 2142220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.